| 货号 | 17593-10mg |
| 描述 | Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear receptor with key roles in adipocyte differentiation and glucose homeostasis.1,2 G3335 is a cell-permeable dipeptide that potently antagonizes PPARγ (Kd = 8.34 µM).3 It reversibly and competitively blocks activation of PPARγ by rosiglitazone (IC50 = 8-32 µM).3 G3335 is active in vivo, abolishing the protective effects of rosiglitazone in experimental spinal cord injury in rats.4 G3335 has also been used to evaluate the role of PPARγ in neurotoxicity studies.5,6 |
| 供应商 | Cayman |
| 应用文献 | |
| 1.Heikkinen, S.,Auwerx, J., and Argmann, C.A. PPARγ in human and mouse physiology. Biochimica et Biophysica Acta 1771(8), 999-1013 (2007). 2.Michalik, L.,Auwerx, J.,Berger, J.P., et al. International union of pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacological Reviews 58, 726-741 (2006). 3.Ye, F.,Zhang, Z.S.,Luo, H.B., et al. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARγ: Bioassay with molecular modeling simulation. ChemBioChem 7, 74-82 (2006). 4.Meng, Q.Q.,Liang, X.J.,Wang, P., et al. Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury. Neuroscience Letters 503, 191-195 (2011). 5.Di Cesare Mannelli, L.,Zanardelli, M.,Micheli, L., et al. PPAR-γ impairment alters peroxisome functionality in primary astrocyte cell cultures. Biomed.Res.Int. 2014, 1-12 (2014). 6.Zanardelli, M.,Micheli, L.,Cinci, L., et al. Oxaliplatin neurotoxicity involves peroxisome alterations. PPARγ agonism as preventive pharmacological approach. PLoS One 9(7), 1-15 (2014). | |
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 333.3 |
| 分子式 | C16H19N3O5 |
| CAS号 | 36099-95-3 |
| 稳定性 | ≥ 2 years |
| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |